Clinical Trial: Trial to Assess the Efficacy of Combination Formula of Aspirin Plus Clopidogrel in Patients With Coronary Stent
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Multicenter, Randomized, Open Study, Investigator-initiated Trial for Comparison of Eight Weeks Efficacy and Tolerability of Clopirin and Clopidogrel With Aspirin in Korean Patients With Post-Percutan
Brief Summary: The purpose of this study in to evaluate efficacy and tolerability of Clopirin and clopidogrel with aspirin in Korean Patients with post-percutaneous coronary artery intervention.
Detailed Summary:
Sponsor: Jeil Pharmaceutical Co., Ltd.
Current Primary Outcome: % inhibition =△Purinergic receptor, G-protein coupled, 12 Reaction Units(PRU)/ Pretreatment PRU [ Time Frame: 8 weeks ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- △ PRU = Post treatment PRU - Pre treatment PRU [ Time Frame: 8 weeks ]
- △ ARU = Post treatment Aspirin resistance unit(ARU) - Pre treatment ARU [ Time Frame: 8 weeks ]
Original Secondary Outcome: Same as current
Information By: Jeil Pharmaceutical Co., Ltd.
Dates:
Date Received: March 19, 2015
Date Started: November 2012
Date Completion:
Last Updated: March 12, 2017
Last Verified: March 2015
